67-4

64/90

384tion of inhibitory mechanisms in pseudo-al-lergy involving Mrgprb2/MRGPRX2-medi-ated mast cell activation. J Allergy Clin Immunol, 2019; 143: 1231-1235.) Nikopoulos K, Cisarova K, Quinodoz M, Koskiniemi-Kuendig H, Miyake N, Farinelli P, Rehman AU, Khan MI, Prunotto A, Akiyama M, Kamatani Y, Terao C, Miya F, Ikeda Y, Ueno S, Fuse N, Murakami A, Wada Y, Terasaki H, Sonoda KH, Ishibashi T, Kubo M, Cremers FPM, Kutalik Z, Matsumoto N, Nishiguchi KM, Nakazawa T, Rivolta C: A frequent variant in the Japanese population determines quasi-Mendelian inheritance of rare retinal ciliopathy. Nat Commun, 2019; 10: 2884.) Inomata T, Nakamura M, Iwagami M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hirat-suka Y, Uchino M, Tsubota K, Dana R, Murakami A: Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm. Ophthalmology, 2019; 126: 766-768.) Nishiguchi KM, Ikeda Y, Fujita K, Kunikata H, Akiho M, Hashimoto K, Hosono K, Kurata K, Koyanagi Y, Akiyama M, Suzuki T, Kawa-saki R, Wada Y, Hotta Y, Sonoda KH, Murakami A, Nakazawa M, Nakazawa T, Abe T: Pheno-typic Features of Oguchi Disease and Reti-nitis Pigmentosa in Patients with S-Antigen Mutations: A Long-Term Follow-up Study. Ophthalmology, 2019; 126: 1557-1566.) Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hirat-suka Y, Uchino M, Tsubota K, Dana R, Murakami A: Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application. JAMA Ophthalmology, 2019; 138: 58-68.) Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, Inai C, Iwasaki Y, Kumano M, Murakami Y, Omodaka K, Abe T, Komori S, Gao D, Hirakata T, Kurata K, Hosono K, Ueno S, Hotta Y, Murakami A, Terasaki H, Wada Y, Nakazawa T, Ishibashi T, Ikeda Y, Kubo M, Sonoda KH: Genetic 3 4 5 6 7characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet, 2019; 56: 662-670.＊ 8) Hirakata T, Lee HC, Ohba M, Saeki K, Okuno T, Murakami A, Matsuda A, Yokomizo T: Dietary ω-3 fatty acids alter the lipid medi-ator profile and alleviate allergic conjuncti-vitis without modulating T(h)2 immune responses. FASEB J, 2019; 33: 3392-3403.) Miyazaki D, Fukagawa K, Fukushima, Fujishima H, Uchio E, Ebihara N, Shoji J, Takamura E, Namba K, Ohashi Y, Okamoto S, Satake Y, Ohtsu H, Shimizu Y, Inoue Y: Air pollution significantly associated with severe ocular allergic inflammatory diseases Sci Rep, 2019; 9: 18205. 9 10) Asada Y, Okano M, Ishida W, Iwamoto S, Fukuda K, Hirakata T, Tada N, Fukushima A, Ebihara N, Kudo A, Matsuda A: Periostin deletion suppresses late-phase response in mouse experimental allergic conjunctivitis. Allergol Int, 2019; 68: 233-239. 11) Honda S, Namekata K, Kimura A, Guo X, Harada C, Murakami A, Matsuda A, Harada T: Survival of Alpha and Intrinsically Photo-sensitive Retinal Ganglion Cells in NMDA-In-duced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma. Invest Ophthalmol Vis Sci, 2019; 60: 3696-3707. 12) Okumura Y, Inomata T, Iwagami M, Eguchi A, Mizuno J, Shiang T, Kawasaki S, Shimada A, Inada E, Amano A, Murakami A: Short-ened cataract surgery by standardisation of the perioperative protocol according to the Joint Commission International accreditation: a retrospective observational study. BMJ Open, 2019; 9: e028656. 13) Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, Okumura Y, Iwata N, Eguchi A, Hasegawa H, Kinouchi H, Murakami A, Kobayashi H: Reliability and Validity of the Japanese Version of the Ocular Surface Disease Index for Dry Eye Disease. BMJ Open, 2019; 9: e033940. 14) Okumura Y, Inomata T, Miyamoto S, Naka-tani S, Hiratsuka Y, Yamaguchi M, Iwamoto S, Murakami A: Donor characteristics and risk factors for methicillin-resistant Staphy-lococcus aureus contamination in storage